| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |